Northstar Wealth Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$642K Hold
7,384
0.3% 79
2020
Q2
$644K Sell
7,384
-496
-6% -$42.8K 0.27% 91
2020
Q1
$649K Sell
7,880
-870
-10% -$77.6K 0.33% 79
2019
Q4
$828K Buy
8,750
+65
+0.7% +$5.83K 0.34% 86
2019
Q3
$755K Hold
8,685
0.33% 87
2019
Q2
$793K Sell
8,685
-1,395
-14% -$118K 0.35% 84
2019
Q1
$868K Buy
10,080
+11
+0.1% +$883 0.4% 73
2018
Q4
$774K Hold
10,069
0.41% 71
2018
Q3
$777K Sell
10,069
-32
-0.3% -$2.37K 0.37% 78
2018
Q2
$683K Sell
10,101
-1,099
-10% -$75.8K 0.34% 87
2018
Q1
$811K Buy
+11,200
New +$853K 0.41% 76

Other funds holding NVS

Northstar Wealth Partners's NVS Position: Q3 2020 in Review

Northstar Wealth Partners held its Novartis (NVS) position steady in Q3 2020 at 7,384 shares worth $642K. The position accounts for 0.3% of the portfolio, ranked #79.

Northstar Wealth Partners first reported a position in NVS in Q1 2018 and has held it in 11 quarters since. The position peaked at $868K in Q1 2019. 1,119 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • Northstar Wealth Partners held 7,384 shares of Novartis worth $642K as of Q3 2020.
  • Northstar Wealth Partners left its Novartis share count unchanged in Q3 2020.
  • Novartis made up 0.3% of Northstar Wealth Partners's portfolio in Q3 2020, its #79 holding.
  • Northstar Wealth Partners first reported a position in Novartis in Q1 2018 and has held it in 11 quarters since.
  • Northstar Wealth Partners's Novartis position peaked at $868K in Q1 2019.
  • 1,119 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.